Abstract
BackgroundA multi-biomarker disease activity (MBDA) score has been shown to reflect disease activity at the molecular level in patients with rheumatoid arthritis (RA). The use of MBDA or its components...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
